K Tatsumi, B Hannhart, CK Pickett, JV Weil and LG Moore
Cardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, Denver 80262.

Hypoxic (HVR) and hypercapnic ventilatory responses (HCVR) are known to be influenced by the administration of testosterone, but whether the hormone acts centrally or peripherally is unknown. To determine whether testosterone alters HVR, HCVR, and carotid sinus nerve (CSN) responsiveness to hypoxia, we compared the ventilatory and CSN responses of neutered male cats treated with testosterone with those of placebo-treated cats. Testosterone treatment increased resting ventilation and CO2 production but did not change end-tidal or arterial PCO2, implying that alveolar ventilation per unit CO2 production was unaltered. Testosterone treatment raised the HVR shape parameter A value 63% in the awake animals (from 16.9 +/- 4.2 to 28 +/- 4, p < 0.05) and 69% in the anesthetized cats (from 22.4 +/- 0.9 to 37.8 +/- 3.7, p < 0.05). Testosterone also augmented the HCVR slope S in awake cats (from 0.17 +/- 0.02 to 0.25 +/- 0.04, p < 0.05). Placebo treatment did not change HVR or HCVR. The CSN response to hypoxia was greater in the testosterone-treated than in the placebo-treated animals (A = 53.6 +/- 7.1 versus 27.1 +/- 5.5 respectively, p < 0.05). The crossplot of the simultaneously measured CSN activity and ventilation during progressive hypoxia showed that the central nervous system translation of CSN output into ventilation was similar in the hormone- and placebo- treated groups. Unilateral, proximal sectioning of the CSN decreased the ventilatory and the CSN responses to hypoxia in the testosterone- treated animals but not in the placebo group. These results indicated that testosterone increased hypoxic and hypercapnic ventilatory responsiveness and increased hypoxic sensitivity of the carotid body.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C. Julien, A. Bairam, and V. Joseph Chronic intermittent hypoxia reduces ventilatory long-term facilitation and enhances apnea frequency in newborn rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1356 - R1366. [Abstract] [Full Text] [PDF]

				E. Dubuis DHEA treatment of pulmonary hypertension: New insights into a complex mechanism Cardiovasc Res, June 1, 2007; 74(3): 337 - 338. [Full Text] [PDF]

				A. G. Zabka, G. S. Mitchell, and M. Behan Conversion from testosterone to oestradiol is required to modulate respiratory long-term facilitation in male rats J. Physiol., November 1, 2006; 576(3): 903 - 912. [Abstract] [Full Text] [PDF]

				J. H Mateika, Q. Omran, J. A Rowley, X. S Zhou, M. P Diamond, and M. S. Badr Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males J. Physiol., December 1, 2004; 561(2): 637 - 646. [Abstract] [Full Text] [PDF]

				X. S. Zhou, J. A. Rowley, F. Demirovic, M. P. Diamond, and M. S. Badr Effect of testosterone on the apneic threshold in women during NREM sleep J Appl Physiol, January 1, 2003; 94(1): 101 - 107. [Abstract] [Full Text] [PDF]

				V. Y. POLOTSKY, J. A. WILSON, M. C. SMALDONE, A. S. HAINES, P. D. HURN, C. G. TANKERSLEY, P. L. SMITH, A. R. SCHWARTZ, and C. P. O'DONNELL Female Gender Exacerbates Respiratory Depression in Leptin-deficient Obesity Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1470 - 1475. [Abstract] [Full Text] [PDF]

				X. S. Zhou, S. Shahabuddin, B. R. Zahn, M. A. Babcock, and M. S. Badr Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep J Appl Physiol, July 1, 2000; 89(1): 192 - 199. [Abstract] [Full Text] [PDF]

				K. Tatsumi, C. K. Pickett, C. R. Jacoby, J. V. Weil, and L. G. Moore Role of endogenous female hormones in hypoxic chemosensitivity J Appl Physiol, November 1, 1997; 83(5): 1706 - 1710. [Abstract] [Full Text] [PDF]